It's a REALLY bad idea to use the general public as test subjects. People think the corona vaccine (that went through extremely thorough testing in a short time period) is suspect and crap like this is only going to encourage the idea that the FDA is bought and paid for by big Pharma.What was the result of phase 1 clinical trials regarding the safety of the drug?
If this drug is well tolerated, then I see no reason it shouldn't get early approval pending post approval study. I know the efficacy data is limited and it probably either doesn't work or only works a little, but people with this disease deserve a chance of a better outcome.
From what I can tell there have been no positive results AT ALL above what placebo does in early onsets and looking at the formulation of the drug (a methyl chain specifically) it would fry the liver in the dosages required.
There already is another variant that works with once a week intramuscular injections where that wouldn't be a problem but it's not as "convenient" and it comes from BioNTech, it's not approved for anything by the FDA but is in third trial in Spain, Sweden and Finland where it will be rolled out later this year if all goes according to plan. BioNTech has already signed with a European producer though so that might have something to do with the very politically motivated and lobbied FDA's decision.